If you take levodopa for Parkinson's, you need to know about this new pill.
Levodopa needs the brain cells that Parkinson's is killing.
Tavapadon doesn't.
It skips the dying cells and goes straight to the receivers, the cells that turn dopamine into movement.
FDA-approved in September. Once a day. Sold as Juvmo.
It doesn't replace lost cells. But it's a genuinely new option to ask your neurologist about.
https://t.co/0zyaOnOTBl
Definitely,
Japan approved a similar one already, USA has several companies including this bemdaneprocel and couple more in end stage clinical trials.
Apart from that Europe, China and Korea are also running similar trials successfully.
But this all depends some important aspects
1. Has to be PD patients … currently doctors can misclassify Parkinsonism symptoms (which includes other diseases other than Parkinson’s). Correct diagnosis is necessary
2. Something was driving these cells in the brain to die in the first place. It differs from patient to patient. And finding that before transplant is crucial.
That’s what I will focus on next
FDA Fast Track: New Brain Cells for Parkinson's
The FDA is fast-tracking a treatment that puts new brain cells into people with Parkinson’s.
It skipped an entire stage of testing.
Its final trial compares it against fake surgery, so we’ll know if it really works.
Answers could come in 2027.
https://t.co/oR13yVa0cP via @YouTube
The first few patients were dosed in 2025. So the data should start coming out in 2027. But they are still recruiting for the trial. So I have a feeling they will keep rolling results over the next few years.
The aspen trial also has been fast tracked so they should start recruiting for their third trial soon too.
I am looking forward to that because they use the patients own skin cells to make stem cells. That cuts down immunosuppression,
The FDA is fast-tracking a treatment that puts new brain cells into people with Parkinson’s.
It skipped an entire stage of testing.
Its final trial compares it against fake surgery, so we’ll know if it really works. Answers could come in 2027.
https://t.co/Qb4yoJhlK9
@davidasinclair Interesting ... So the signal isn’t about domestication, it’s that chronic infection and poor nutrition speed up the epigenetic clock.
Could this link with the stanford study that showed mortality risk is linked mainly to brain and the immune system?
@C1_dF9432 This is definitely a choice.
Plus, hundreds of patients and stem cell transplants are a success. One patient died in the European trial due to an infection after immunosuppression, but not from surgery.
So overall highly effective but we have a lot of homework to do.
Schizophrenia is highly polygenic, so one variant only nudges risk.
That’s why the effect is small, and why the occipital lobe finding matters too.
Neanderthal DNA isn’t good or bad, it’s context, and this is a nice reminder that our brains are partly built from an ancient hybrid blueprint.
Great question, and it’s EXACTLY why I’m making this podcast series.
Scientists did these trials a long time ago ...Older donor-cell transplants survived 10 to 24 years in some people. But years later, some of those new cells had started to show Parkinson’s damage too. The disease process didn’t stop just because fresh cells arrived.
That’s the key point. New cells can replace what was lost, but if we don’t find and treat what’s driving Parkinson’s in the first place, whether it’s inflammation, the gut, genes or something else, it can slowly damage the new cells as well.
Finding that PD driver is key and it differs from person to person. There is gut first PD linked to the gut and then there's body first PD that is linked to diseases, infections, genetics, environment, diet, exercise and much more. Finding that unique driver is ESSENTIAL prior to the stem cell transplant in my opinion.
So the series looks at both sides ... the treatments that put cells back, and the root causes we need to fix so those cells last.
I am still trying to figure out how to approach each situation and educate people and also medical professionals. It's actually hard to tell any of this to a neurologist who is still stuck on old methods and keeps misdiagnosing PD patients.
@ScienceBriefs Sleep isn’t just a personal habit, it’s shaped by the world around us: noise, housing, safety, shift work, stress. In this data the gap is a few minutes per unit of score, so it’s a signal, not a verdict.
But it shows how inequality ends up showing up in our biology.
Interesting. This fits the idea of “local sleep,” where parts of the brain dip into sleep-like activity while we’re awake.
What I’d want to know next is which comes first. Are these slow waves a marker of Parkinson’s pathology, or do they help drive the hallucinations and cognitive decline? It’s an association right now, but it could give us a measurable signal to track, and maybe target, before things get worse.
@bichikota This is pretty much trials running all over the world now in Japan, USA, Europe, China and Korea with great success in clinical trials.
In Parkinson's the dopamine producing neurons die and they never come back. No new cells get made. This is the only reversal method.
That’s a really fair question, and it does sound strange at first.
Here’s the surprising thing about Parkinson’s. When people truly believe they’ve had a treatment that will help, their brain releases a little extra dopamine, all on its own. Scientists have seen this on brain scans. So someone can feel genuinely better for months after a surgery that did nothing, simply because they hoped it would work. They aren’t imagining it. Their brain is really doing it.
That’s why the trial needs a comparison group. Some people get the new cells, and some get a “pretend” surgery, where the surgeon makes a small, shallow mark on the skull without touching the brain. Nobody knows which one they had. If the people who got the real cells do clearly better, we know the cells work, not just the hope.
This has caught researchers out before. Years ago, cell transplants looked amazing, until they were tested this way and most of the benefit disappeared.
And the pretend surgery group isn’t left out. Once the main results are in, they may be able to get the real cells.
This is why independent oversight matters.
The animal data showing liver damage existed, but the warning never reached the people approving the trial, and the consent form didn’t list death as a risk.
Gene therapy is too promising, and too risky, to run without a regulator checking the work.
This is where FDA shines a bit more than others. They do have strict guidelines (usually).
Thank you for sharing this.
The “it’s natural, so it’s safe” idea worries me most.
Kratom acts on the same opioid receptors as prescription painkillers, and 7-OH is a far more potent compound that the body can also make from mitragynine.
Natural doesn’t mean mild, and a gas station shelf isn’t where an opioid belongs.
The “it’s natural, so it’s safe” idea worries me most.
Kratom acts on the same opioid receptors as prescription painkillers, and 7-OH is a far more potent compound that the body can also make from mitragynine.
Natural doesn’t mean mild, and a gas station shelf isn’t where an opioid belongs.